Dyadic International Inc. (DYAI) vs Seres Therapeutics, Inc. (MCRB)
- Dyadic International Inc. DYAI 0.33 −5.71%
- Seres Therapeutics, Inc. MCRB 1.40 −0.71%
Dyadic International Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Dyadic International Inc. and Seres Therapeutics, Inc. are of similar size ($14.4M and $14.0M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −98.3%. Dyadic International Inc. has the higher net margin (−226.9% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 16 metrics below, Dyadic International Inc. leads on 12 and Seres Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | DYAI | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | 100.00% | 67.24% |
| Operating margin | (237.12%) | (3,656.89%) | 0.00% |
| Net margin | (226.87%) | (2,209.55%) | 0.00% |
| Free cash flow margin | (227.93%) | (2,997.74%) | 0.00% |
| Return on equity | (47,310.78%) | (144.35%) | (50.28%) |
| Return on assets | (71.43%) | (44.85%) | (45.89%) |
| Return on invested capital | 0.00% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack